JP2024522385A5 - - Google Patents
Info
- Publication number
- JP2024522385A5 JP2024522385A5 JP2023554016A JP2023554016A JP2024522385A5 JP 2024522385 A5 JP2024522385 A5 JP 2024522385A5 JP 2023554016 A JP2023554016 A JP 2023554016A JP 2023554016 A JP2023554016 A JP 2023554016A JP 2024522385 A5 JP2024522385 A5 JP 2024522385A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- positions
- fusion
- immunogenic composition
- hmpv
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21167609.3 | 2021-04-09 | ||
| EP21167609 | 2021-04-09 | ||
| PCT/EP2022/059492 WO2022214678A2 (en) | 2021-04-09 | 2022-04-08 | Human metapneumo virus vaccine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024522385A JP2024522385A (ja) | 2024-06-19 |
| JP2024522385A5 true JP2024522385A5 (https=) | 2025-04-15 |
Family
ID=75441775
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023554016A Pending JP2024522385A (ja) | 2021-04-09 | 2022-04-08 | ヒトメタニューモウイルスワクチン |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20240181034A1 (https=) |
| EP (2) | EP4319802A2 (https=) |
| JP (1) | JP2024522385A (https=) |
| KR (1) | KR20230167017A (https=) |
| CN (1) | CN117279659A (https=) |
| AU (1) | AU2022255923A1 (https=) |
| BR (1) | BR112023017274A2 (https=) |
| CA (1) | CA3210412A1 (https=) |
| MX (1) | MX2023010370A (https=) |
| WO (2) | WO2022214685A2 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3972639A1 (en) | 2019-05-20 | 2022-03-30 | Valneva SE | A subunit vaccine for treatment or prevention of a respiratory tract infection |
| US20240252614A1 (en) | 2023-01-18 | 2024-08-01 | Pfizer Inc. | Vaccines against respiratory diseases |
| WO2025119162A1 (zh) * | 2023-12-04 | 2025-06-12 | 深圳深信生物科技有限公司 | 偏肺病毒(mpv)疫苗 |
| WO2025126071A1 (en) | 2023-12-14 | 2025-06-19 | Pfizer Inc. | Rna molecules |
| WO2026018181A1 (en) | 2024-07-17 | 2026-01-22 | Pfizer Inc. | Immunogenic compositions and uses thereof |
| CN119971017B (zh) * | 2025-04-16 | 2025-08-05 | 北京华诺泰生物医药科技有限公司 | 一种hmpv疫苗组合物 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5547871A (en) | 1993-01-25 | 1996-08-20 | American Cyanamid Company | Heterologous signal sequences for secretion of insect controlling proteins |
| EP1167379A3 (en) | 1994-07-15 | 2004-09-08 | University Of Iowa Research Foundation | Immunomodulatory oligonucleotides |
| AT408721B (de) | 1999-10-01 | 2002-02-25 | Cistem Biotechnologies Gmbh | Pharmazeutische zusammensetzung enthaltend ein antigen |
| AT410173B (de) | 2000-06-08 | 2003-02-25 | Cistem Biotechnologies Gmbh | Antigene zusammensetzung |
| AT410635B (de) | 2000-10-18 | 2003-06-25 | Cistem Biotechnologies Gmbh | Vakzin-zusammensetzung |
| WO2002094845A2 (en) | 2001-05-21 | 2002-11-28 | Intercell Ag | Method for stabilising of nucleic acids |
| EP1608402B1 (en) | 2003-03-24 | 2010-10-20 | Intercell AG | Improved vaccines |
| EP3269386B1 (en) | 2011-12-06 | 2022-09-14 | Valneva Austria GmbH | Aluminium compounds for use in therapeutics and vaccines |
| WO2016103238A1 (en) * | 2014-12-24 | 2016-06-30 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Recombinant metapneumovirus f proteins and their use |
| WO2019092002A1 (en) * | 2017-11-07 | 2019-05-16 | Valneva Se | Pharmaceutical compositions for treatment or prevention of viral infections |
| EP3972639A1 (en) * | 2019-05-20 | 2022-03-30 | Valneva SE | A subunit vaccine for treatment or prevention of a respiratory tract infection |
-
2022
- 2022-04-08 KR KR1020237028871A patent/KR20230167017A/ko active Pending
- 2022-04-08 US US18/285,416 patent/US20240181034A1/en active Pending
- 2022-04-08 WO PCT/EP2022/059502 patent/WO2022214685A2/en not_active Ceased
- 2022-04-08 AU AU2022255923A patent/AU2022255923A1/en not_active Abandoned
- 2022-04-08 BR BR112023017274A patent/BR112023017274A2/pt unknown
- 2022-04-08 CN CN202280015950.4A patent/CN117279659A/zh active Pending
- 2022-04-08 MX MX2023010370A patent/MX2023010370A/es unknown
- 2022-04-08 WO PCT/EP2022/059492 patent/WO2022214678A2/en not_active Ceased
- 2022-04-08 JP JP2023554016A patent/JP2024522385A/ja active Pending
- 2022-04-08 US US18/285,417 patent/US20240358812A1/en active Pending
- 2022-04-08 CA CA3210412A patent/CA3210412A1/en active Pending
- 2022-04-08 EP EP22716270.8A patent/EP4319802A2/en active Pending
- 2022-04-08 EP EP22719593.0A patent/EP4319804A2/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024522385A5 (https=) | ||
| US11229694B2 (en) | Vaccine against RSV | |
| US12162909B2 (en) | Subunit vaccine for treatment or prevention of a respiratory tract infection | |
| ES3058501T3 (en) | Rsv f protein mutants | |
| JPH11508769A (ja) | Ｃ型肝炎に対するワクチン | |
| IL200341A (en) | Method for the preparation of immunogenic particles containing influenza a m2e protein fused to hepatitis b virus core protein | |
| JP2024508683A5 (https=) | ||
| CN117279659A (zh) | 人偏肺病毒疫苗 | |
| JPH07508520A (ja) | 組合せポリペプチド抗原 | |
| JP2025509352A5 (https=) | ||
| CN117396493A (zh) | 氨基酸、核苷酸和表达它们的载体及其在预防沙贝病毒感染中的用途 | |
| RU2811991C2 (ru) | Субъединичная вакцина для лечения или предотвращения инфекции дыхательных путей | |
| AU2018342997C1 (en) | Cutaneous papilloma virus vaccine | |
| JP2024518565A (ja) | 組換え重複ペプチド及びネイティブタンパク質を含むワクチン製剤 | |
| HK40051815A (en) | Vaccine against rsv comprising modified f polypeptide | |
| HK40098178A (zh) | 人偏肺病毒疫苗 | |
| RU2023124900A (ru) | Композиции, содержащие адъюванты sbi, и способы их применения | |
| HK1250939B (en) | Vaccine against rsv |